VEROVACCiNES

Halle, Germany Founded: 2017 • Age: 9 yrs
Developer of animal vaccines to treat infectious diseases

About VEROVACCiNES

VEROVACCiNES is a company based in Halle (Germany) founded in 2017. VEROVACCiNES offers products and services including Subunit Vaccine Platform and Recombinant Yeast Strains. VEROVACCiNES operates in a competitive market with competitors including Merck Animal Health, TARGAN, Aptimmune Biologics, Indian Immunologicals and ViroVet, among others.

  • Headquarter Halle, Germany
  • Sectors
    Healthcare
    Agriculture
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website verovaccines.com
  • Social LinkedIn
  • Legal Name Eqmania Ug
Key Metrics

Products & Services of VEROVACCiNES

VEROVACCiNES offers a comprehensive portfolio of products and services, including Subunit Vaccine Platform and Recombinant Yeast Strains.

Subunit Vaccine Platform
Biotech Platform

Platform for rapid creation and optimization of animal vaccines using yeast strains.

Recombinant Yeast Strains
Molecular Biology Tool

Strains that express antigens for vaccine development in animal health.

Funding Insights of VEROVACCiNES

  • Total Rounds 2
  • Investors Count 2

All 2 funding rounds of VEROVACCiNES with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2019–Grant––
Dec 2019–Seed–HTGF
–
Valuation history

2 investors in total: 2 institutional.

Investors in VEROVACCiNES

VEROVACCiNES has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include GO-Bio and High-Tech Gründerfonds.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Early-stage investments are made in high-tech startups by HTGF.
–htgf.deBonn, Germany
Funding is provided for biotechnology research and innovation projects.
–go-bio.deGermany
Premium access

Investor details for VEROVACCiNES

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of VEROVACCiNES

2 dated milestones of VEROVACCiNES across 2 years, from founding to its latest funding, stage changes and deals.

  1. Founded VEROVACCiNES is founded.
  2. Funding First funding round.

Competitors of VEROVACCiNES

VEROVACCiNES operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck Animal Health, TARGAN, Aptimmune Biologics, Indian Immunologicals and ViroVet, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
merck-animal-health.com1921Madison, United States–2,952
Vaccine technology is developed and supplied for livestock animals.
targan.com2015Morrisville, United States–29
Automated targeted vaccine systems for livestock and aquaculture are developed.
aptimmune.com2010Champaign, United States$11.05M3
Swine vaccines are developed using advanced mucosal technology.
indimmune.com1982Hyderabad, India–1,810
Vaccines for animal and human health are manufactured.
virovet.com2015Leuven, Belgium$13.63M14
Manufacturer and supplier of antiviral drugs for livestock
vitamfero.com2005Angers, France$6.72M–
Offers patented immunostimulating vaccines for livestock.
intervacc.se2001Stockholm, Sweden––
Recombinant vaccines for cattle, equine, and other livestock are developed.
pacificgenetech.com2009Hong Kong, China$10M–
Developer of vaccines and gene delivery platform
harrisvaccines.com2005Ames, United States$5M–
Developer of vaccine technology for the treatment of infectious diseases
Premium access

Detailed competitors of VEROVACCiNES

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to VEROVACCiNES

10 companies that operate in the same segment as VEROVACCiNES (Veterinary Digital Health), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Practice and prescription management software is provided for veterinary professionals.
2010Portland, Oregon, United StatesUSD 291.64 M––
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
2012Brussels, Brussels-capital Region, Belgium–––
Veterinary pharmacy services are delivered by VetSource to practices.
2005Portland, Oregon, United StatesUSD 81.25 M––
Animal health therapeutics are developed and supplied globally by Ceva.
1999Libourne, Nouvelle-aquitaine, FranceUSD 214.35 M––
Digital platform for pet insurance
2020Stockholm, SwedenUSD 114.08 M––
App based platform providing veterinary services and clinical management solutions for veterinarians
2018Beverly Hills, California, United StatesUSD 58.81 M––
Online client communication platform for veterinary doctors
2013San Diego, California, United StatesUSD 14.11 MUSD 14.38 M1
Virtual veterinary care is provided via an app platform.
2018Los Angeles, California, United StatesUSD 210 M–163
Comprehensive customer engagement platform for veterinary clinics is provided.
2015Austin, Texas, United StatesUSD 50.3 M––
Veterinary appointments are booked via an online platform.
2017Brooklyn, New York, United StatesUSD 243 M–64
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about VEROVACCiNES

VEROVACCiNES was founded in 2017 and raised its 1st funding round 2 years after it was founded.

VEROVACCiNES is headquartered in Halle, Germany. It is registered at Halle, Sachsen-anhalt, Germany.

VEROVACCiNES was founded in 2017 in Halle, Germany, within the biotechnology sector focused on animal health. Novel vaccines are developed for treating infectious diseases in animals, utilizing recombinant strains of the yeast Kluyveromyces lactis. Antigens are expressed by these strains to target various pathogens. Operations center on research and production of these specialized immunizations, with a presence maintained through the domain verovaccines.com.

VEROVACCiNES's top competitors include TARGAN, Merck Animal Health and Indian Immunologicals.

VEROVACCiNES offers Subunit Vaccine Platform and Recombinant Yeast Strains.

VEROVACCiNES has 2 investors. Key investors include GO-Bio, and High-Tech Gründerfonds.

VEROVACCiNES operates through Eqmania Ug.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available